Contents Experimental ProceduresTable S1.Crystallographic data for 2b•0.5(CH 2 ClCH 2 Cl) and 2c•C 6 H 5 Me

Cyclic trinuclear complexes [Pd(3)(mu-pz)(6)] (1) and [Pd(3)(mu-4-Mepz)(6)] (2) and dinuclear complex [Pd(2)(mu-3-t-Bupz)(2)(3-t-Bupz)(2)(3-t-BupzH)(2)] (3) have been prepared by the reactions of [PdCl(2)(CH(3)CN)(2)] with pyrazole (pzH), 4-methylpyrazole (4-MepzH), and 3-tert-butylpyrazole (3-t-BupzH), respectively, in CH(3)CN in the presence of Et(3)N. In the absence of the base, treatment of [PdCl(2)(CH(3)CN)(2)] with pzH gave the mononuclear complex, [Pd(pzH)(4)]Cl(2) (6). The reaction of [PtCl(2)(C(2)H(5)CN)(2)] with pzH in the presence of Et(3)N under refluxing in C(2)H(5)CN afforded the known dimeric Pt(II) complex, [Pt(pz)(2)(pzH)(2)](2) (7). The protons participating in the hydrogen bonding in 3 and 7 are easily replaced by silver ions to give the heterotetranuclear complex [Pd(2)Ag(2)(mu-3-t-Bupz)(6)] (4) and the heterohexanuclear complex [Pt(2)Ag(4)(mu-pz)(8)] (5). The complexes 1-6 are structurally characterized.

for the active site of the metalloenzyme have been developed. These complexes also showed NOR activity. Finally, an NO reduction cycle in the diruthenium system is described.